Zhejiang Hisoar Pharmaceutical Co., Ltd.

SZSE:002099 Rapport sur les actions

Capitalisation boursière : CN¥8.5b

La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Zhejiang Hisoar Pharmaceutical Bilan de santé

Santé financière contrôle des critères 3/6

Zhejiang Hisoar Pharmaceutical has a total shareholder equity of CN¥5.5B and total debt of CN¥1.3B, which brings its debt-to-equity ratio to 24%. Its total assets and total liabilities are CN¥7.7B and CN¥2.1B respectively.

Informations clés

24.0%

Ratio d'endettement

CN¥1.33b

Dette

Ratio de couverture des intérêtsn/a
Argent liquideCN¥1.60b
Fonds propresCN¥5.54b
Total du passifCN¥2.11b
Total des actifsCN¥7.65b

Mises à jour récentes de la santé financière

Recent updates

Zhejiang Hisoar Pharmaceutical (SZSE:002099) Has Debt But No Earnings; Should You Worry?

May 27
Zhejiang Hisoar Pharmaceutical (SZSE:002099) Has Debt But No Earnings; Should You Worry?

Zhejiang Hisoar Pharmaceutical Co., Ltd.'s (SZSE:002099) Shares Climb 28% But Its Business Is Yet to Catch Up

Mar 03
Zhejiang Hisoar Pharmaceutical Co., Ltd.'s (SZSE:002099) Shares Climb 28% But Its Business Is Yet to Catch Up

Analyse de la situation financière

Passif à court terme: 002099's short term assets (CN¥2.8B) exceed its short term liabilities (CN¥1.9B).

Passif à long terme: 002099's short term assets (CN¥2.8B) exceed its long term liabilities (CN¥216.9M).


Historique et analyse du ratio d'endettement

Niveau d'endettement: 002099 has more cash than its total debt.

Réduire la dette: 002099's debt to equity ratio has increased from 10.1% to 24% over the past 5 years.

Couverture de la dette: 002099's debt is not well covered by operating cash flow (8.2%).

Couverture des intérêts: Insufficient data to determine if 002099's interest payments on its debt are well covered by EBIT.


Bilan


Découvrir des entreprises saines